Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Voltarol Joint & Back Pain Relief 2.32% Gel
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Diclofenac diethylammonium may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
What it is and what it is used for
for
This medicine contains the active substance diclofenac which belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs). It is specially formulated for rubbing into the skin. Voltarol Joint & Back Pain Relief 2.32% Gel is used to relieve pain and reduce inflammation and swelling in a number of painful conditions affecting the joints and muscles. This medicine can be used to treat: • muscle and joint injuries (e.g. sprains, strains, bruises, backache, sports injuries), relieving pain and helping recovery back to normal function; • tendonitis (e.g. tennis elbow), swelling around elbow or knee. Voltarol Joint & Back Pain Relief 2.32% Gel is intended for use in adults and children aged 14 years and older.
2. What you need to know about Voltarol Joint & Back Pain Relief 2.32% Gel:
Do not use this medicine if you: • are allergic (hypersensitive) to diclofenac or other medicines used to treat pain, fever or inflammation, such as ibuprofen or aspirin (a substance also used to prevent blood clotting), or any of the other ingredients of this medicine (see Section 6 and end of Section 2). If you are not sure, ask your doctor or pharmacist. Symptoms of an allergic reaction may include: wheezing or shortness of breath (asthma); skin rash with blisters or hives; swelling of the face or tongue; runny nose. • have severe joint pain of recent onset that is not related to an injury or period of overuse. • feel ill, have a temperature or any other symptoms that accompany the pain. • are in the last 3 months of pregnancy. If any of these apply to you, do not use this medicine. Take special care with Voltarol Joint & Back Pain Relief 2.32% Gel • Do not apply the gel to skin that has (i) a rash or eczema (ii) cuts or open wounds. Stop the treatment if a skin rash develops after applying the product. • Avoid applying on large areas of skin and over a prolonged period of time, unless under medical advice. • Be careful when sunbathing or using sun lamps as your skin may be more sensitive to sunlight. • This medicine is only for use on your skin. Do not use it in the mouth. Do not swallow it. Wash your hands after use unless they are the area to be treated. Be careful not to get Voltarol Joint & Back Pain Relief 2.32% Gel in your eyes. If this happens, rinse your eyes well with clean water. See your doctor or pharmacist if any discomfort persists. • Due to an increased possibility of side effects, take care if you are using any other medicine containing diclofenac or painkillers known as NSAIDs, such as aspirin or ibuprofen.
• • • •
A brace or wrap commonly used for injuries like sprains can be used, but do not use the gel under airtight (plastic) bandages. If you have a stomach or duodenal ulcer (or a history of), tell your doctor or pharmacist before using the gel. If you have or have ever had asthma speak to your doctor or pharmacist before using the gel. Do not smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings, etc.) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
If you have any questions, talk to your doctor or pharmacist before using Voltarol Joint & Back Pain Relief 2.32% Gel. This medicine is not recommended for use in children under 14 years of age. Taking other medicines with Voltarol Joint & Back Pain Relief 2.32% Gel Please tell your doctor or pharmacist if you are taking, or have recently taken, or want to start taking any other medicines, including those obtained without a medical prescription. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. This medicine must not be used during the last 3 months of pregnancy, as it could harm your unborn child or cause problems at delivery. Voltarol Joint & Back Pain Relief 2.32% Gel should only be used under medical advice during the first 6 months of pregnancy and the dose should be kept as low and duration of treatment as short as possible. This medicine should only be used under medical advice during breast-feeding as diclofenac passes into breast milk in small amounts. However, Voltarol Joint & Back Pain Relief 2.32% Gel should not be applied on the breasts of nursing mothers nor elsewhere on large areas of skin or for a prolonged period of time. Consult your doctor or pharmacist for further information if you are pregnant or breast-feeding. Oral forms (e.g. tablets) of diclofenac can cause adverse effects in your unborn baby. It is not known if the same risk applies to diclofenac when it is used on the skin. Effects of other ingredients (excipients) Voltarol Joint & Back Pain Relief 2.32% Gel contains: • propylene glycol, which may cause a mild localised skin irritation in some people. • butylhydroxytoluene, which may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.
How to take it
Voltarol Joint & Back Pain Relief 2.32% Gel
Always use this medicine exactly as described in this leaflet. You should check with your doctor or pharmacist if you are not sure. How much Voltarol Joint & Back Pain Relief 2.32% Gel to use
For adults and adolescents 14 years and over. Apply the gel 2 times a day (preferably morning and evening) on the painful area. How to apply Voltarol Joint & Back Pain Relief 2.32% Gel 1. 2.
To remove the seal before first use, unscrew and remove the cap. Use the reverse side of the cap to insert, twist and remove the seal from the tube. Gently squeeze out a small amount of gel from the tube and apply to the painful or swollen area, slowly rubbing into the skin. The amount needed will vary depending upon the size of the painful or swollen area; an amount ranging in size from a 1 penny to a 2 pence piece will usually be sufficient (2-4 g). You may notice a slight cooling effect when you rub the gel in. Only use the smallest amount of this medicine needed to relieve your pain but never use more than 8 g per day and 56 g in one week.
This medicine is for use only on your skin. After application: Unless they are the site being treated, the hands should be wiped with a tissue and then washed, to avoid accidental contact with the mouth and eyes. The tissue should be disposed of in the household waste and not in the toilet to prevent the product reaching the wastewater system. Before dressing or applying a non-airtight bandage, let the gel dry for a few minutes on the skin. If you need to shower or to bathe, apply the product afterwards How long to use Voltarol Joint & Back Pain Relief 2.32% Gel for Do not use this medicine for more than 14 days unless longer treatment is recommended by a doctor.
If the pain and swelling do not improve within 7 days, or if they get worse, tell your doctor. In children aged 14 years and over, if this product is required for more than 7 days for pain relief or if the symptoms worsen the patient/parents of the adolescent is/are advised to consult a doctor. If you use more Voltarol Joint & Back Pain Relief 2.32% Gel than you should
- If you use more gel than you should, wipe off the surplus gel with a tissue.
- If you or a child accidentally swallows the gel, contact your doctor immediately. If you forget to use Voltarol Joint & Back Pain Relief 2.32% Gel If you miss your application of this medicine at the correct time, apply it when you remember and then carry on as normal. Do not apply a double quantity to make up for the forgotten application. If you have any further questions on the use of this product, ask your doctor or pharmacist.
Possible side effects
Like all medicines, Voltarol Joint & Back Pain Relief 2.32% Gel can cause side effects, although not everybody gets them. Some rare and very rare side effects might be serious If you experience any of the following signs of allergy, STOP using this medicine and tell a doctor or pharmacist immediately: • Skin rash with blisters; hives. (These side effects are likely to affect 1 to 10 people in every 10,000). • Wheezing, shortness of breath or feeling of tightness in the chest (asthma). (These side effects are likely to affect less than 1 person in every 10,000). • Swelling of the face, lips, tongue or throat. (These side effects are likely to affect less than 1 person in every 10,000). Other side effects which may occur are usually mild, passing and harmless (if you are concerned, tell a doctor or pharmacist). Common side effects (likely to affect between 1 and 10 in every 100 patients)
- Skin rash, itching, reddening or smarting of the skin Very rare side effects (likely to affect less than 1 in every 10,000 patients)
- The skin may be more sensitive to the sun. Possible signs are sunburn with itching, swelling and blistering. Some side effects have unknown frequency (cannot be estimated from available information): • local application site irritation, peeling of the skin and skin discolouration. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
How to store it
Voltarol Joint & Back Pain Relief 2.32% Gel
- Keep out of the sight and reach of children.
- Do not use this medicine after the expiry date which is stated on the carton and tube after EXP.
- Do not store above 30 °C.
- Do not dispose of medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. What is in the pack and further information
What Voltarol Joint & Back Pain Relief 2.32% Gel contains The active substance is diclofenac diethylammonium. Each gram of gel contains 23.2 mg of diclofenac diethylammonium. The other ingredients are butylhydroxytoluene, carbomers, cocoyl caprylocaprate, diethylamine, isopropyl alcohol, liquid paraffin, macrogol cetostearyl ether, oleyl alcohol, propylene glycol, perfume eucalyptus sting and purified water (see end of Section 2 for further information). What Voltarol Joint & Back Pain Relief 2.32% Gel looks like and contents of the pack This medicine is a white to practically white, cooling, non-greasy, non-staining cream-like gel. The product comes in packs of 30 g and 50 g. Not all pack sizes may be marketed.
Marketing Authorisation Holder Haleon UK Trading Limited, The Heights, Weybridge, KT13 0NY, U.K Manufacturer Manufacturer Haleon UK Trading Services Limited, Building 5, First Floor, The Heights, Brooklands, Weybridge, KT13 0NY, United Kingdom. This leaflet was last revised in November 2025. Trade Marks are owned by or licensed to the Haleon group of companies.
Frequently asked questions about Voltarol Joint & Back Pain Relief 2.32% Gel
How do I take Voltarol Joint & Back Pain Relief 2.32% Gel?
Voltarol Joint & Back Pain Relief 2.32% Gel comes as gel. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Voltarol Joint & Back Pain Relief 2.32% Gel?
The active substance in Voltarol Joint & Back Pain Relief 2.32% Gel is diclofenac diethylammonium.
Are there equivalent medicines to Voltarol Joint & Back Pain Relief 2.32% Gel?
Medicines with the same active substance, strength and form include: Voltarol 1.16% Emulgel, gel, Voltarol Back and Muscle Pain Relief 1.16% Gel, Voltarol Max Strength Pain Relief 2.32% Gel. In total there are 4 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Voltarol Joint & Back Pain Relief 2.32% Gel, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Voltarol Joint & Back Pain Relief 2.32% Gel without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: diclofenac diethylammonium
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
For the local symptomatic relief of pain and inflammation in:
- trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises
- localised forms of soft tissue rheumatism
4.2. Posology and method of administration
For cutaneous use only
The gel is applied to the affected parts of the body and gently rubbed into the skin. Afterwards, the hands should be wiped with a paper towel and then washed, unless the hands are the area to be treated.
If too much gel is accidentally applied, the excess gel should be wiped with a paper towel.
The paper towel should be disposed in the household waste to prevent unused product reaching the aquatic environment.
Before applying a bandage, the gel should be left to dry for a few minutes on the skin.
Adults and children aged 14 years and over: Depending on the size of the affected site to be treated 2-4g (a circular shaped mass approximately 2.0-2.5cm in diameter) of gel should be applied 2 times daily (preferably morning and evening). The maximum daily dose is 8g. Therefore the maximum weekly dose is 56g.
If symptoms persist after 7 days or get worse at any time, medical advice should be sought.
Not to be used for more than 14 days unless recommended by a doctor.
Use in the elderly: The usual adult dosage may be used.
Children and adolescents: There are insufficient data on efficacy and safety available for the children and adolescents below 14 years of age (see also contraindications section 4.3). In children aged 14 years and over, if this product is required for more than 7 days for pain relief or if the symptoms worsen the patient/parents of the adolescent is/are advised to consult a doctor.
4.3. Contraindications
Patients with or without chronic asthma in whom asthma, angioedema, urticaria or acute rhinitis are precipitated by aspirin or other non-steroidal anti-inflammatory agents.
Hypersensitivity to diclofenac, acetylsalicylic acid or other non-steroidal anti- inflammatory drugs.
Hypersensitivity to any other ingredient of the gel.
During the last trimester of pregnancy.
4.4. Special warnings and precautions for use
The possibility of experiencing systemic adverse events (those associated with the use of systemic forms of diclofenac) from application of this medicine cannot be excluded if the preparation is used at higher dosage/large amounts over large areas of skin and/or over a prolonged period (see the product information of systemic forms of diclofenac e.g. oral or injection for systemic adverse reactions).
Concomitant use of systemic NSAIDs should be cautioned since the possibility of an increase in incidence of untoward effects, particularly systemic side effects, cannot be ruled out.
This medicine should be applied only to intact, non-diseased skin and not to skin wounds or open injuries. It should not be used with occlusion. It should not be allowed to come into contact with the eyes or mucous membranes, and should never be taken by mouth.
Patients with a history of, or active, peptic ulceration. Some possibility of gastro-intestinal bleeding in those with a significant history of this condition has been reported in isolated cases.
Like other drugs that inhibit prostaglandin synthetase activity, diclofenac and other NSAIDs can precipitate bronchospasm if administered to patients suffering from or with a previous history of asthma or allergic disease.
Discontinue the treatment if rash develops after applying the product. Patients should be warned against excessive exposure to sunlight in order to reduce the incidence of photosensitivity.
Information concerning excipients
This medicine contains propylene glycol, which may cause mild, localised skin irritation in some people. It also contains butylhydroxytoluene which may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.
Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
4.5. Interaction with other medicinal products and other forms of interaction
Since systemic absorption of diclofenac from a topical application is very low such interactions are very unlikely. There are no known interactions with this medicine, but for a list of interactions known with oral diclofenac the SPCs for oral dosage forms should be consulted.
4.6. Fertility, pregnancy and lactation
Fertility
There are no data available on the use of topical formulations of diclofenac and its effects on fertility in humans.
Pregnancy
There is no clinical data from the use of diclofenac during pregnancy.
The systemic concentration of diclofenac is lower after topical administration, compared to oral formulations. Even if systemic exposure is lower compared with oral administration, it is not known if the systemic diclofenac exposure reached after topical administration can be harmful to an embryo/fetus. With reference to experience from treatment with NSAIDs with systemic uptake, the following is recommended:
Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/fetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5 %. The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo- fetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period. During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.
During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to:
- cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);
- renal dysfunction, which may progress to renal failure with oligo- hydroamniosis;
The mother and the neonate, at the end of pregnancy, to:
- possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses.
- inhibition of uterine contractions resulting in delayed or prolonged labour.
Consequently, diclofenac is contraindicated during the third trimester of pregnancy (see section 4.3).
Lactation
Like other NSAIDs, diclofenac passes into breast milk in small amounts. However, at therapeutic doses of this medicine no effects on the suckling child are anticipated. Because of a lack of controlled studies in lactating women, the product should only be used during lactation under advice from a healthcare professional. Under this circumstance, this medicine should not be applied on the breasts of nursing mothers, nor elsewhere on large areas of skin or for a prolonged period of time (see section 4.4).
4.7. Effects on ability to drive and use machines
This medicine has no or negligible influence on the ability to drive and use machines.
4.8. Undesirable effects
Undesirable effects include mild and passing skin reactions at the site of application. In very rare instances, allergic reactions may occur.
Adverse reactions are listed below, by system organ class and frequency. Frequencies are defined as: very common (≥ 1/10) common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Infections and infestations
Very rare: Rash pustular
Immune system disorders
Very rare: Hypersensitivity (including urticaria), angioedema
Respiratory, thoracic and mediastinal disorders
Very rare: Asthma
Skin and subcutaneous tissue disorders
Common: Dermatitis (including contact dermatitis), rash, erythema, eczema, pruritus.
Rare: Dermatitis bullous.
Very rare: Photosensitivity reaction
Not known: Desquamation, skin discolouration
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store
4.9. Overdose
Signs and symptoms
The low systemic absorption of topical diclofenac renders overdose very unlikely. However undesirable effects, similar to those observed following an overdose of diclofenac tablets, can be expected if this medicine is inadvertently ingested (e.g. 1 tube of 50 g contains the equivalent of 1 g diclofenac sodium.)
Treatment
Management of overdosage with NSAIDs essentially consists of supportive and symptomatic measures. There is no typical clinical picture resulting from diclofenac overdosage. Supportive and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastro- intestinal irritation, and respiratory depression; specific therapies such as forced diuresis, dialysis or haemoperfusion are probably of no help in eliminating NSAIDs due to their high rate of protein binding and extensive metabolism.
In the event of accidental ingestion, resulting in significant systemic adverse effects, general therapeutic measures normally adopted to treat poisoning with non-steroidal anti-inflammatory medicines should be used. The use of activated charcoal should be considered especially within a short time (within one hour) of ingestion of a toxic dose.
💬 Ask about this leaflet
Ask anything about Voltarol Joint & Back Pain Relief 2.32% Gel. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.